Literature DB >> 18041108

A nanoparticulate drug-delivery system for rivastigmine: physico-chemical and in vitro biological characterization.

Emanuela Fabiola Craparo1, Giovanna Pitarresi, Maria Luisa Bondì, Maria Pia Casaletto, Mariano Licciardi, Gaetano Giammona.   

Abstract

The preparation and characterization of surface-PEGylated polymeric nanoparticles are described. These systems were obtained by UV irradiation of PHM and PHM-PEG(2000) as an inverse microemulsion, using an aqueous solution of the PHM/PHM-PEG(2000) copolymer mixture as the internal phase and triacetin saturated with water as the external phase, and characterized by dimensional analysis, zeta-potential measurements and XPS. in vitro biological tests demonstrated their cell compatibility and their ability to escape from phagocytosis. Rivastigmine was encapsulated into the nanoparticle structure and drug-release profiles from loaded samples were investigated in PBS at pH = 7.4 and human plasma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18041108     DOI: 10.1002/mabi.200700165

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  3 in total

1.  Development and validation of a spectrofluorimetric method for the estimation of rivastigmine in formulations.

Authors:  R Kapil; S Dhawan; Bhupinder Singh
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

2.  In Situ-Forming Microparticles for Controlled Release of Rivastigmine: In Vitro Optimization and In Vivo Evaluation.

Authors:  Mohamed Haider; Ibrahim Elsayed; Iman S Ahmed; Ahmed R Fares
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-14

3.  Development and characterization of nanoparticles for the delivery of gemcitabine hydrochloride.

Authors:  Rekha Khaira; Jyoti Sharma; Vinay Saini
Journal:  ScientificWorldJournal       Date:  2014-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.